The multi-step process required to discover and produce a personal neoantigen vaccine for a given patient is time consuming, costly, and inevitably restricted to targeting only a small subset of imperfectly predicted neoantigens, features which limit the therapeutic potential of the current generation of personal neoantigen cancer vaccines. Dionis Therapeutics seeks to revolutionize the personal cancer vaccine space by utilizing a proprietary approach.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Concord, Ma 01742, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Concord, MA
Dionis Therapeutics Questions
Dionis Therapeutics's LinkedIn profile is https://www.linkedin.com/company/dionis-therapeutics
Dionis Therapeutics has
1 employees.
View email and phone details for 1
employees at Dionis Therapeutics.
Dionis Therapeutics's industry is
Biotechnology Research
Dionis Therapeutics's top competitors are
Acir,
Vaccine And Immunotherapy Center,
Affini-T Therapeutics,
Wrench Bio,
Precision Oncology Consulting, Plc,
Rnp Therapeutics,
Ucir,
Immunepcs,
Precision Medicine. Driven By Ai.,
Glyde Bio, Inc..
Dionis Therapeutics's categories are Biotechnology Research
Dionis Therapeutics's founding year is 2022
